Genetic Diversification of a Single Bluetongue Virus Strain Using an In Vitro Model
Christina
May 17, 2021
The Genetic Diversification of a Single Bluetongue Virus Pressure Utilizing an In Vitro Mannequin of Alternating-Host Transmission
Bluetongue virus (BTV) is an arbovirus that has been related to dramatic epizootics in each wild and residential ruminants in latest a really very long time. As a segmented, double-stranded RNA virus, BTV can evolve by a variety of mechanisms attributable to its genomic constructing. Nonetheless, the have an effect on of BTV’s alternating-host transmission cycle on the virus’s genetic diversification stays poorly understood. Full genome sequencing approaches present a platform for investigating the have an effect on of host-alternation all by all ten segments of BTV’s genome.
To know the function of alternating hosts in BTV’s genetic diversification, a subject isolate was passaged beneath three totally completely totally different circumstances: (i) serial passages in Culicoidessonorensis cells, (ii) serial passages in bovine pulmonary artery endothelial cells, or (iii) alternating passages between insect and bovine cells.
Aliquots of virus had been sequenced, and single nucleotide variants had been acknowledged. Measures of viral inhabitants genetics had been used to quantify the genetic diversification that occurred. Two consensus variants in segments 5 and 10 occurred in virus from all three circumstances.
Whereas variants arose all by all passages, measures of genetic differ remained largely comparable all by cell customized circumstances. Irrespective of passage in a relaxed in vitro system, we discovered that this BTV isolate exhibited genetic stability all by passages and circumstances. Our findings underscore the expensive function that full genome sequencing could play in enhancing understanding of viral evolution and spotlight the genetic stability of BTV.

agresearchforum
Human epithelial specific antigen,ESA ELISA Kit |
YLA2715HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
Monoclonal Anti-Human Epithelial Specific Antigen (ESA/EpCAM-1/CD326) IgG |
ESA11-M |
Alpha Diagnostics |
100 ug |
EUR 578.4 |
Prostate Specific Antigen Std Grade Antigen |
VAng-Cr3891-1mg |
Creative Biolabs |
1 mg |
EUR 604.8 |
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation. |
Epithelial Membrane Antigen (MUC1) Antibody |
20-abx121644 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Epithelial Membrane Antigen (MUC1) Antibody |
20-abx123255 |
Abbexa |
|
|
|
Epithelial Membrane Antigen (MUC1) Antibody |
20-abx133246 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx020564-1mg |
Abbexa |
1 mg |
EUR 1011.6 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx020565-1mg |
Abbexa |
1 mg |
EUR 961.2 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx020566-1mg |
Abbexa |
1 mg |
EUR 1011.6 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx020567-1mg |
Abbexa |
1 mg |
EUR 1011.6 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx020569-1mg |
Abbexa |
1 mg |
EUR 961.2 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx020571-1mg |
Abbexa |
1 mg |
EUR 961.2 |
|
Epithelial Membrane Antigen (EMA) Antibody |
abx022470-02mg |
Abbexa |
0.2 mg |
EUR 1128 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx023797-1mg |
Abbexa |
1 mg |
EUR 1011.6 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx025382-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx025382-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx235427-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Epithelial Membrane Antigen (MUC1) Antibody |
abx235428-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Mouse Anti-Human Ep-CAM/Epithelial Specific Antigen monoclonal antibody, clone JID678 |
CABT-L2933-100uL500uL |
Creative Diagnostics |
100 uL, 500 uL |
EUR 602.4 |
Prostate Specific Antigen Antibody |
49127-100ul |
SAB |
100ul |
EUR 399.6 |
Prostate Specific Antigen Antibody |
49127-50ul |
SAB |
50ul |
EUR 286.8 |
Prostate-specific Antigen Antibody |
33477-100ul |
SAB |
100ul |
EUR 302.4 |
Prostate-specific Antigen Antibody |
33477-50ul |
SAB |
50ul |
EUR 224.4 |
Epithelium Specific Antigen antibody |
10R-E126A |
Fitzgerald |
50 ug |
EUR 501.6 |
Description: Mouse monoclonal Epithelium Specific Antigen antibody |
Prostate-specific antigen Antibody |
abx140217-01mg |
Abbexa |
0.1 mg |
EUR 393.6 |
|
Prostate-specific antigen Antibody |
abx020585-1mg |
Abbexa |
1 mg |
EUR 577.2 |
|
Prostate-specific antigen Antibody |
abx020586-1mg |
Abbexa |
1 mg |
EUR 844.8 |
|
Prostate-specific antigen Antibody |
abx020587-1mg |
Abbexa |
1 mg |
EUR 961.2 |
|
Prostate-specific antigen Antibody |
abx020588-1mg |
Abbexa |
1 mg |
EUR 961.2 |
|
Prostate-specific antigen Antibody |
abx020591-1mg |
Abbexa |
1 mg |
EUR 661.2 |
|
Prostate-specific antigen Antibody |
abx020592-1mg |
Abbexa |
1 mg |
EUR 661.2 |
|
Prostate-specific antigen Antibody |
abx020593-1mg |
Abbexa |
1 mg |
EUR 661.2 |
|
Prostate-specific antigen Antibody |
abx020594-1mg |
Abbexa |
1 mg |
EUR 661.2 |
|
Prostate-specific antigen Antibody |
abx020595-1mg |
Abbexa |
1 mg |
EUR 661.2 |
|
Prostate-specific antigen Antibody |
abx020596-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
Prostate-specific antigen Antibody |
abx020597-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Prostate-specific antigen Antibody |
abx020598-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Prostate-specific antigen Antibody |
abx020599-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Prostate-specific antigen Antibody |
abx020600-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Prostate-specific antigen Antibody |
abx020601-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Prostate-specific antigen Antibody |
abx020604-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
Prostate-specific antigen Antibody |
abx022531-1mg |
Abbexa |
1 mg |
EUR 777.6 |
|
Prostate-specific antigen Antibody |
abx022532-1mg |
Abbexa |
1 mg |
EUR 811.2 |
|
Prostate-specific antigen Antibody |
abx022533-1ml |
Abbexa |
1 ml |
EUR 510 |
|
Prostate-specific antigen Antibody |
abx022534-1ml |
Abbexa |
1 ml |
EUR 493.2 |
|
Prostate-specific antigen Antibody |
abx022535-1mg |
Abbexa |
1 mg |
EUR 444 |
|
Prostate-specific Antigen Antibody |
20-abx013184 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Prostate Specific Antigen (≥90%) |
VAng-Cr3889-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
Description: Prostate Specific Antigen, Host/Source: Human Seminal Fluid. The purity is ≥90% by SDS-PAGE. |
Prostate Specific Antigen (≥96%) |
VAng-Cr3890-1mg |
Creative Biolabs |
1 mg |
EUR 1693.2 |
Description: Prostate Specific Antigen, Host/Source: Human Seminal Fluid. The purity is ≥96% by SDS-PAGE. |
anti-Prostate Specific Antigen |
YF-PA10281 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to Prostate Specific Antigen |
anti-Prostate Specific Antigen |
YF-PA10282 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to Prostate Specific Antigen |
Erythrocyte Specific Antigen Antibody |
V2337-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody detects an erythrocyte specific antigen. The antibody shows a well defined reactivity with cells of the erythroid lineage at all stages of maturation in the peripheral blood, bone marrow, and fetal liver. Non-erythroid lineages are negative by flow cytometry. Although the exact identity of the erythrocyte specific antigen has yet to be determined, it has been shown to be distinct from Glycophorin A. This antibody is useful in the diagnosis of erythroleukemia, identification of bone marrow erythroid precursors, gating erythroid nucleated precursor cells from malignant cells in bone marrow specimens. |
Erythrocyte Specific Antigen Antibody |
V2337-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody detects an erythrocyte specific antigen. The antibody shows a well defined reactivity with cells of the erythroid lineage at all stages of maturation in the peripheral blood, bone marrow, and fetal liver. Non-erythroid lineages are negative by flow cytometry. Although the exact identity of the erythrocyte specific antigen has yet to be determined, it has been shown to be distinct from Glycophorin A. This antibody is useful in the diagnosis of erythroleukemia, identification of bone marrow erythroid precursors, gating erythroid nucleated precursor cells from malignant cells in bone marrow specimens. |
Erythrocyte Specific Antigen Antibody |
V2337SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody detects an erythrocyte specific antigen. The antibody shows a well defined reactivity with cells of the erythroid lineage at all stages of maturation in the peripheral blood, bone marrow, and fetal liver. Non-erythroid lineages are negative by flow cytometry. Although the exact identity of the erythrocyte specific antigen has yet to be determined, it has been shown to be distinct from Glycophorin A. This antibody is useful in the diagnosis of erythroleukemia, identification of bone marrow erythroid precursors, gating erythroid nucleated precursor cells from malignant cells in bone marrow specimens. |
Hepatocyte Specific Antigen Antibody |
V2341-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC's occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V2341-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC's occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V2341IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC's occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V2341SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC's occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V3109-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Hepatocyte Paraffin 1 or HepPar-1 localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC s occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V3109-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Hepatocyte Paraffin 1 or HepPar-1 localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC s occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V3109IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Hepatocyte Paraffin 1 or HepPar-1 localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC s occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V3109SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Hepatocyte Paraffin 1 or HepPar-1 localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC s occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V3131-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Monoclonal antibodies (mAbs) to liver cell processes are useful in the identification of hepatic carcinomas and normal organ structures. mAb HSA98 binds to human hepatocytes and the majority of human hepatocellular carcinomas (HCCs). In frozen sections, it stains hepatic cells and may be used as a marker of the liver. Cell preparations of hepatocellular carcinoma biopsies or cell lines are found to bind HSA98 on the cell surface. This mAb stains liver hepatocytes in frozen human liver sections and is positive on the cell surface of human liver carcinomas. |
Hepatocyte Specific Antigen Antibody |
V3131-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Monoclonal antibodies (mAbs) to liver cell processes are useful in the identification of hepatic carcinomas and normal organ structures. mAb HSA98 binds to human hepatocytes and the majority of human hepatocellular carcinomas (HCCs). In frozen sections, it stains hepatic cells and may be used as a marker of the liver. Cell preparations of hepatocellular carcinoma biopsies or cell lines are found to bind HSA98 on the cell surface. This mAb stains liver hepatocytes in frozen human liver sections and is positive on the cell surface of human liver carcinomas. |
Hepatocyte Specific Antigen Antibody |
V3131SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Monoclonal antibodies (mAbs) to liver cell processes are useful in the identification of hepatic carcinomas and normal organ structures. mAb HSA98 binds to human hepatocytes and the majority of human hepatocellular carcinomas (HCCs). In frozen sections, it stains hepatic cells and may be used as a marker of the liver. Cell preparations of hepatocellular carcinoma biopsies or cell lines are found to bind HSA98 on the cell surface. This mAb stains liver hepatocytes in frozen human liver sections and is positive on the cell surface of human liver carcinomas. |
Hepatocyte Specific Antigen Antibody |
V3173-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: mAb HSA133 stains human liver canaliculi and a subset of hepatocellular carcinomas. In frozen sections, it stains liver canaliculi strongly and may be used as a marker of this hepatic substructure. Cell preparations of hepatocellular carcinoma biopsies and cell lines are found to bind this mAb on the cell surface. HSA133 strongly stains liver canaliculi and hepatic carcinoma cells using frozen sections or paraformaldehyde fixed cell preparations. |
Hepatocyte Specific Antigen Antibody |
V3173-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: mAb HSA133 stains human liver canaliculi and a subset of hepatocellular carcinomas. In frozen sections, it stains liver canaliculi strongly and may be used as a marker of this hepatic substructure. Cell preparations of hepatocellular carcinoma biopsies and cell lines are found to bind this mAb on the cell surface. HSA133 strongly stains liver canaliculi and hepatic carcinoma cells using frozen sections or paraformaldehyde fixed cell preparations. |
Hepatocyte Specific Antigen Antibody |
V3173SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: mAb HSA133 stains human liver canaliculi and a subset of hepatocellular carcinomas. In frozen sections, it stains liver canaliculi strongly and may be used as a marker of this hepatic substructure. Cell preparations of hepatocellular carcinoma biopsies and cell lines are found to bind this mAb on the cell surface. HSA133 strongly stains liver canaliculi and hepatic carcinoma cells using frozen sections or paraformaldehyde fixed cell preparations. |
Hepatocyte Specific Antigen Antibody |
V9119-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCCs occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V9119-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCCs occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V9119IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCCs occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Hepatocyte Specific Antigen Antibody |
V9119SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or Hep Par 1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCCs occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors. |
Epithelial Membrane Antigen (MUC1) Antibody Pair |
abx117512-1pair5x96wellplates |
Abbexa |
1 pair (5x96 well plates) |
EUR 1212 |
|
Epithelial Membrane Antigen; Clone E29 (Concentrate) |
A00008-C |
ScyTek Laboratories |
1 ml |
EUR 596.4 |
Epithelial Membrane Antigen; Clone E29 (Concentrate) |
A00008-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 165.6 |
Lung Specific Antigen(LSA120) Antibody |
BNCA0120-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Lung Specific Antigen(LSA120), APC conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNCA0133-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), APC conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNCAP0120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNCAP0120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNCAP0133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNCAP0133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC610120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF660R conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC610120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF660R conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC610133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF660R conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC610133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF660R conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC680120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF568 conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC680120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF568 conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC680133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF568 conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC680133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF568 conjugate, Concentration: 0.1mg/mL |
Prostate-specific Antigen Conjugated Antibody |
C33477 |
SAB |
100ul |
EUR 476.4 |
Lung Specific Antigen(LSA120) Antibody |
BNCR0120-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Lung Specific Antigen(LSA120), RPE conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNCR0133-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), RPE conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNUB0120-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), Concentration: 0.2mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNUB0120-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against Lung Specific Antigen(LSA120), Concentration: 0.2mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNUB0133-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), Concentration: 0.2mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNUB0133-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), Concentration: 0.2mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC430120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF543 conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC430120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF543 conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC430133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF543 conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC430133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF543 conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC470120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF647 conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC470120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF647 conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC470133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF647 conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC470133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF647 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen Conjugated Antibody |
C49127 |
SAB |
100ul |
EUR 476.4 |
Lung Specific Antigen(LSA120) Antibody |
BNC400120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF640R conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC400120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF640R conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC400133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF640R conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC400133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF640R conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC880120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF488A conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC880120-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF488A conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC880133-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF488A conjugate, Concentration: 0.1mg/mL |
Hepatocyte Specific Antigen(HSA133) Antibody |
BNC880133-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Hepatocyte Specific Antigen(HSA133), CF488A conjugate, Concentration: 0.1mg/mL |
Lung Specific Antigen(LSA120) Antibody |
BNC810120-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Lung Specific Antigen(LSA120), CF680R conjugate, Concentration: 0.1mg/mL |
Novel Gene Rearrangement and the Full Mitochondrial Genome of Cynoglossusmonopus: Insights into the Envolution of the Household Cynoglossidae (Pleuronectiformes)
Cynoglossusmonopus, a small benthic fish, belongs to the Cynoglossidae, Pleuronectiformes. It was not normally studied attributable to its low abundance and cryptical life-style. With the intention to know the mitochondrial genome and the phylogeny in Cynoglossidae, all of the mitogenome of C. monopus has been sequenced and analyzed for the primary time. The entire dimension is 16,425 bp, usually containing 37 genes with novel gene rearrangements. The tRNA-Gln gene is inverted from the sunshine to the heavy strand and translocated from the downstream of tRNA-Ile gene to its upstream. The administration house (CR) translocated downstream to the three’-end of ND1 gene adjoining to inverted to tRNA-Gln and left a 24 bp hint fragment inside the real place.
The phylogenetic timber had been reconstructed by Bayesian inference (BI) and most chance (ML) strategies based completely on the mitogenomic data of 32 tonguefish species and two outgroups. The outcomes help the concept Cynoglossidae is a monophyletic group and stage out that C. monopus has the closest phylogenetic relationship with C. puncticeps.
By combining fossil data and mitogenome data, the time-calibrated evolutionary tree of households Cynoglossidae and Soleidae was firstly offered, and it was indicated that Cynoglossidae and Soleidae had been differentiated from one another all by Paleogene, and the evolutionary technique of household Cynoglossidae coated the Quaternary, Neogene and Paleogene durations.
Genome-Broad Identification and Characterization of the SHI-Associated Sequence Gene Household in Rice
Rice (Oryzasativa) yield is correlated to varied components. Transcription regulators are essential components, akin to the frequently SHORT INTERNODES-related sequences (SRSs), which encode proteins with single zinc finger motifs. Nonetheless, data concerning the evolutionary and wise traits of the SRS gene household members in rice is inadequate.
Subsequently, we carried out a genome-wide screening and characterization of the OsSRS gene household in Oryzasativa japonica rice. We furthermore examined the SRS proteins from 11 rice sub-species, consisting of three cultivars, 6 wild varieties, and some completely totally different genome sorts. SRS members from maize, sorghum, Brachypodiumdistachyon, and Arabidopsis had been furthermore investigated.
All these SRS proteins exhibited species-specific traits, together with monocot- and dicot-specific traits, as assessed by phylogenetic evaluation, which was additional validated by gene constructing and motif analyses. Genome comparisons revealed that segmental duplications may have carried out crucial roles contained in the recombination of the OsSRS gene household and their expression ranges. The household was primarily subjected to purifying selective stress.
Along with, the expression data demonstrated the distinct responses of OsSRS genes to varied abiotic stresses and hormonal cures, indicating their wise divergence. Our research offers an exquisite reference for elucidating the choices of SRS genes in rice.
A preliminary analysis of a domestically produced biotinylated polyclonal anti-rabies antibody for direct speedy immunohistochemical check (DRIT) within the Philippines
- Rabies is a deadly zoonotic illness endemic in growing international locations of Asia and Africa. Lately, the direct speedy immunohistochemical check (DRIT) was advisable by the World Well being Group (WHO) and the World Group for Animal Well being (OIE) as a diagnostic check for rabies. Subsequently, a biotinylated polyclonal antibody (pAb) towards the rabies lyssavirus (RABV) nucleoprotein was developed utilizing a plasmid cDNA vaccine derived from a problem virus commonplace 11 pressure.
- A preliminary analysis on the efficacy of this reagent in recognizing the Philippine RABV pressure was examined utilizing banked canine hippocampal tissue samples with DRIT and the outcomes have been in comparison with dFAT. The consequences of acetone and formalin fixation on DRIT have been additionally assessed by immunoreactivity scores of the specimens.
- Of the 142 samples examined, 104 examined optimistic and 38 detrimental utilizing each dFAT and DRIT, exhibiting 100% settlement between the 2 diagnostic procedures. Furthermore, no false optimistic or false detrimental outcomes have been noticed utilizing acetone and formalin fixation. Thus, domestically ready biotinylated pAb from plasmid cDNA can be utilized for DRIT, particularly in resource-limited laboratories within the Philippines.
- Nevertheless, these outcomes must be confirmed with a extra thorough analysis of this system, and the vary of detection must be additional evaluated in a bigger panel of animal samples and on different lyssaviruses.